Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 13, 2003 05:00 ET | Source: Active Biotech

Invitation to Annual General Meeting of Shareholders

Active Biotech AB is a biotechnology company focusing on research in and development of pharmaceuticals. Active Biotech has a strong R&D portfolio and pipeline products with focus primarily on...
March 13, 2003 04:51 ET | Source: Active Biotech

Kallelse till bolagsstämma

Kallelsen, som införs idag i Sydsvenskan, Dagens Industri och Post- och Inrikes Tidningar, bifogas. Lund den 13 mars 2003 ACTIVE BIOTECH AB (PUBL)STYRELSEN Active Biotech AB är ett...
February 13, 2003 03:03 ET | Source: Active Biotech

Active Biotech - SEK 225 million (approx. € 25 million) rights issue

Preferential rights will be given to the company's shareholders. According to the board's decision the shares will be issued at a price of SEK 10 per share. One class A share and/or class B share...
February 13, 2003 03:00 ET | Source: Active Biotech

Active Biotech Quarterly Report Oct-Dec, Full Year 2002

For release content, please refer to the attachment....
February 13, 2003 02:46 ET | Source: Active Biotech

Active Biotech - Företrädesemission om 225 Mkr

Nyemissionen ska ske med företräde för bolagets aktieägare. De nya aktierna ska enligt styrelsens beslut emitteras till en kurs om 10 kronor per aktie. En aktie av serie A och/eller serie B berättigar...
February 13, 2003 02:40 ET | Source: Active Biotech

Active Biotech Kvartalsrapport, Okt-Dec 2002, samt helår

For release content, please refer to the attachment....
February 10, 2003 08:44 ET | Source: Active Biotech

Invitation Teleconference - Active Biotech AB

Active Biotech's President & CEO Sven Andréasson and CFO Hans Kolam present and comment on the quarterly report October-December and the full year 2002.To participate in the teleconference,...
February 10, 2003 08:42 ET | Source: Active Biotech

Inbjudan Telekonferens - Active Biotech AB

Active Biotechs VD Sven Andréasson och CFO Hans Kolam presenterar och kommenterar företagets kvartalsrapport oktober-december, samt helåret 2002.För att delta i telefonkonferensen, v.v. ring +44 20...
January 29, 2003 05:20 ET | Source: Active Biotech

Positive results from preliminary clinical studies of Active Biotech's prostate cancer drug

The aim of the study was to study the pharmacokinetic characteristics of the candidate drug in humans, i.e. absorption and excretion. These data have significance for the administration of the...
January 29, 2003 05:16 ET | Source: Active Biotech

Positiva resultat från inledande kliniska studier av Active Biotechs prostatacancer-preparat

Avsikten med studien har varit att studera läkemedelskandidatens farmakokinetiska egenskaper hos människa, d.v.s. hur substansen tas upp och utsöndras. Dessa data har betydelse bland annat för...